Ginger - An herbal medicinal product with broad anti-inflammatory actions

Journal of Medicinal Food

Volumn 8, Issue 2, 2005, Pages 125-132

  Grzanna, Reinhard ^a   Lindmark, Lars ^c   Frondoza, Carmelita G ^b  

^a RMG Biosciences Inc   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ferrosan AS   (Denmark)

Author keywords

Chemokines; Cyclooxygenase; Cytokines; Ginger; Inflammation

Indexed keywords

3 METHOXY 4 HYDROXYPHENOL DERIVATIVE; ACETOXYCHAVICOL ACETATE; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; CHEMOKINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GINGER EXTRACT; GINGEROL; HERBACEOUS AGENT; HYDROXYL GROUP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KETONE DERIVATIVE; LEUKOTRIENE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PARADOL; PHENOL DERIVATIVE; PROSTAGLANDIN; SHOGAOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; ZINGERONE;

ALPINA GALANGA; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; CARTILAGE CELL; CHRONIC INFLAMMATION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG SAFETY; GENE INDUCTION; GINGER; HERBAL MEDICINE; HUMAN; NONHUMAN; OSTEOARTHRITIS; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATIC DISEASE; STRUCTURE ACTIVITY RELATION; SYNOVIOCYTE; ZINGIBERACEAE;

ALPINIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; ARTHRITIS; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE INHIBITORS; CYTOKINES; GINGER; HUMANS; MONOCYTES; NF-KAPPA B; PAIN; PLANT EXTRACTS; PLANTS, MEDICINAL; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, DRUG; RHEUMATIC DISEASES;

ANIMALIA; KAEMPFERIA GALANGA; ZINGIBER OFFICINALE; ZINGIBERACEAE;

EID: 22444431608     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.8.125     Document Type: Review

References (76)

1. Afzal M, Al-Hadidi D, Menon M, Pesek M, Dhami MSI: Ginger: An ethnomedical, chemical and pharmacological review. Drug Metab Drug Interact 2001;18:159-190.
2. Awang DVC: Ginger. Can Pharmaceut J 1992;125:309-311.
3. Leung AY: Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, John Wiley and Sons, New York, 1980.
4. Blumenthal M: The Complete German Commission E Monographs, Americal Botanical Council, Boston, 1998.
5. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971;231:232-235.
6. Kiuchi F, Shibuya M, Sankawa U: Inhibitors of prostaglandin biosynthesis from ginger. Chem Pharm Bull (Tokyo) 1982;30: 754-757.
7. Flynn DL, Rafferty MF: Inhibition of human neurotrophil 5-lipoxygenase activity by gingerdione, shagaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med 1986;24: 195-198.
8. Celotti F, Laufer S: Anti-inflammatory drugs: New multitarget compounds to face an old problem. The dual inhibition concept. Pharmacol Res 2001;43:429-436.
9. Fiorucci S, Meli R, Bucci M, Cirino G: Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue to anti-inflammatory therapy? Biochem Pharmacol 2001;62:1433-1438.
10. Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier J-P: Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2003;62:501-509.
11. Dinarello CA: Anti-cytokine therapeutics and infections. Vaccine 2003;21(Suppl):S2/24-S22/34.
12. http://www.herbmed.org/herbs/herb138.htm (accessed 18 April 2005).
13. Altman RD, Marcussen KC: Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44: 2461-2462.
14. Bliddal H, Rosetzky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt H-H, Christensen K, Jensen ON, Barsley J: A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000;8:9-12.
15. Wigler I, Grotto I, Caspi D, Yaron M: The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis Cartilage 2003;11:783-789.
16. Duke JA: Handbook of Medicinal Herbs, CRC Press, Boca Raton, FL, 2002.
17. Ma J, Jin XJ, Yang L, Liu Z-L: Diarylheptanoids from the rhizomes of Zingiber officinale. Phytochemistry 2004;65:1137-1143.
18. 2 production. Phytochemistry 2004;65:1937-1954.
19. Charles R, Garg SN, Kumar S: New gingerdione from the rhizomes of Zingiber officinale. Fitoterapia 2000;71:716-718.
20. Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC: Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 2001;29: 156-163.
21. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U: Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diaryl heptanoids. Chem Pharm Bull (Tokyo) 1992;40:387-391.
22. McLaughlin JL, Rogers LL, Anderson JE: The use of biological assays to evaluate botanicals. Drug Inform J 1998;32:513-524.
23. Srivastava K: Isolation and effects of some ginger compounds on platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med 1986;25:187-198.
24. Vane JR, Bakhele YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
25. Warner TD, Mitchell JA: Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic. FASEB J 2004;18:790-804.
26. Sertie JAA, Basile AC, Oshiro TT, Silva FD, Mazella AAG: Preventive anti-ulcer activity of the rhizome extract of Zingiber officinale. Fitoterapia 1992;63:55-59.
27. Yoshikawa M, Yamagashi S, Kumini K, Matsuda H, Okuno Y, Yamashara J, Murakami A: Stomachic principles in ginger. An anti-ulcer principle 6-gingesulfonic acid, and three monoacyldigalactosylglycerols gingerglycolipids A, B, and C, from Zingiber rhizome originating in Taiwan. Chem Pharm Bull (Tokyo) 1994;42:226-230.
28. Yamahara J, Mochizuki M, Rong HQ, MAtsuda H, Fujimura H: The anti-ulcer effect in rats of ginger constituents. J Ethnopharmacol 1988;23:299-304.
29. Hudson N, Balsitis M, Everitt S, Hawkey CJ: Enhanced gastric mucosal leukotriene B4synthesis in patients taking non-steroidal antiinftammatory drugs. Gut 1993;34:742-747.
30. Asako H, Kubes P, Wallace J, Wolf RE, Granger DN: Indomethacin-induced leukocyte adhesion in mesenteric venules: Role of lipoxygenase products. Am J Physiol 1992;262:G903-G908.
31. Nickerson-Nutter CL, Medvedeff ED: The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation. Arthritis Rheum 1996;39:515-521.
32. Laufer S: Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 2003;15:623-627.
33. Srivastava KC, Mustafa T: Ginger (Zingiber officinale) and rheumatic disorders. Med Hypotheses 1989;29:25-28.
34. Srivastava K, Mustafa T: Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992;39: 342-348.
35. Choy EHS, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-916.
36. Bremner P, Heinrich M: Natural products as targeted modulators of the nuclear factor-κB pathway. J Pharm Pharmacol 2001;54: 453-472.
37. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K: Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;17:1943-1944.
38. Chang Y-L, Shen J-J, Wung B-S, Cheng J-J, Wang DL: Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001;60:507-513.
39. Suh N, Honda T, Finlay HJ, Barchowsky A, Williams C, Benoit NE, Xie Q-W, Nathan C, Gribble GW, Sporn MB: Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenases (COX-2) in mouse macrophages. Cancer Res 1998;58:717-723.
40. Lam T, Ling T, Chowdhury C, Chao T-H, Bahjat FR, Lloyd GK, Moldawer LL, Palladino MA, Theodorakis EA: Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents. Bioorg Med Chem Lett 2003;13:3217-3221.
41. Murakami A, Takahashi D, Kinoshita T, Koshima K, Kim HW, Yoshihiro A, Nakamura Y, Jiwajinda S, Ohigashi H: Zerumbone, a Southeast Asian ginger sequiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: The α,β-unsaturated carbonyl group is a prerequisite. Carcinogenesis 2002;23: 795-802.
42. Pelletier J-P, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD: Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo- controlled trial. The Diacerein Study Group. Arthritis Rheum 2000;43:2339-2348.
43. Martel-Pelletier J: Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 2003;11:1-3.
44. Frondoza CG, Frazier C, Polotsky A, Lahiji K, Hungerford DS: TNF-alpha expression of synoviocyte cultures is inhibited by hydroxy-alkoxy-phenyl compounds (HAPC) from ginger. Trans Orthop Res Soc 2000;46:1038.
45. Frondoza CG, Frazier C, Polotsky A, Lahiji K, Hungerford DS, Weidner M: Inhibition of chondrocyte and synoviocyte TNF-α expression by hydroxy-alkoxy-phenyl compounds (HAPC) [abstract]. In: 3rd Symposium, International Cartilage Repair Society, Gothenburg, Sweden, 2000, p. 35.
46. Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS. Lindmark L: An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro 2004;30:95-101.
47. Phan P, Sohrabi A, Polotsky A, Lindmark L, Hungerford DS, Lindmark L, Frondoza CG: Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Altern Complement Med 2005;11:149-154.
48. Stack E, DuBois RN: Regulation of cyclo-oxygenase-2. Best Pract Res Clin Gastroenterol 2001;15:787-800.
49. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, Stuchin SA, Patel IR, Abramson SB: Superinduction of cyclcooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231-1237.
50. Kang RY, Freire-Moar J, Sigal E, Chu CQ: Expression of cyclooxygenase-2 in human and animal model of rheumatoid arthritis. Br J Rheumatol 1996;35:711-718.
51. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Hahn KB: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001;480-481:243-268.
52. Lipsky PE: Specific COX-2 inhibitors in arthritis, oncology, and beyond: Where is the science headed? J Rheumatol 1999;26: 25-30.
53. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-959.
54. Housby JN, Cahill CM, Chu B, Prevelige R, Bickford K, Sevenson MA, Calderwood SK: Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes. Cytokine 1998;11:347-358.
55. Carty TJ, Sweeney FJ, Griffiths RJ, Ernest MJ, Pillar JS, Cheng JS, Loose LD, Joseph PA, Pazoles PP, Moore PF, Nagahisa A, Kadin SB: Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in vivo. Inflamm Res 1997;46:168-179.
56. Gonzalez-Scarano F, Baltuch G: Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22:219-240.
57. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
58. Stoll G, Jander S: The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 1999;58:233-247.
59. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy SA, Griffin WST, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydell R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
60. Orr CF, Rowe DB, Halliday GM: An inflammatory review of Parkinson's disease. Prog Neurobiol 2002;68:325-340.
61. Benveniste EN: Role of macrophage/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997;75:165-173.
62. Luc LF, Rydell R, Brigham EF, Yang L-B, Hampel H, Murphy GM Jr, Brachova L, Yan S-D, Waker DG, Shen Y, Roger J: Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 2001;35:72-79.
63. Rozovsky I, Finch CE, Morgan TE: Age-related activation of microglia and astrocytes: In vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging 1998;19:97-103.
64. in t'Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MMB, Stricker BHC: Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-1521.
65. Stewart WT, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-632.
66. Grzanna R, Phan PV, Polotsky A, Lindmark L, Frondoza CG: Ginger extract inhibits β-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 2004;10:1009-1013.
67. Helmuth L: Protecting the brain while killing pain? Science 2002;297:1262-1263.
68. Baeuerle PA, Baichwal VR: NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997;65:111-137.
69. Christman JW, Lancaster LH, Blackwell TS: Nuclear factor κB: A pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 1998;24:1131-1138.
70. Tak PP, Firestein GS: NF-κB: A key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
71. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA: Activation transcription factor NF-κB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-591.
72. Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin invest 2001;107:135-142.
73. Fakata KL: Anti-inflammatory agents for the treatment of musculoskeletal pain and arthritis. Curr Pain Headache Rep 2004;8: 173-177.
74. Schaible HG, Ebersberger A, von Banchet GS: Mechanisms of pain in arthritis. Ann NY Acad Sci 2002;966:343-354.
75. Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, Roufogalis BD: Gingerols: A novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol 2002;137:793-798.
76. He X, Schepelmann K, Schaible HG, Schmidt RF: Capsaicin inhibits responses of fine afferents from the knee joint of the cat to mechanical and chemical stimuli. Brain Res 1990;530: 147-150.